Tscan Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.18

-0.01 (-3.35%)

As of Nov 14, 2:35 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +6,263.1% upside

Low Target $7.11

Average Target $11.39

High Target $14.81

Current Price $0.18

Current
$0.18

Target
$11.39

$7.11 $11.39 avg $14.81

Scenario Analysis

Bear Case

$7.11

3,872.1%

Low target

Base Case

$11.39

+6,263.1%

Avg target

Bull Case

$14.81

+8,173.7%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$1.47

-87.8% from high

52-Week Low

$0.16

+11.7% from low

Target vs 52W High

$11.39

+674.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%